Quarterly report pursuant to Section 13 or 15(d)

STOCKBASED COMPENSATION (Tables)

v3.21.2
STOCKBASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2021
STOCK-BASED COMPENSATION  
Schedule of Equity incentive plan

 

 

Awards Reserved for Issuance

 

 

Awards

Outstanding

 

 

 

 

 

 

 

 

2016 Equity incentive plan

 

 

2,000,000

 

 

 

499,953

 

2018 Equity incentive plan

 

 

43,976,425

 

 

 

15,894,507

 

Schedule of Stock option activity

 

 

Number of

Shares

 

 

Weighted-Average Exercise Price Per Share

 

 

Weighted-Average Remaining Contractual Life

 

Aggregate Intrinsic Value of In-the-Money Options

 

 

 

 

 

 

 

 

Options outstanding as of January 1, 2021

 

 

17,492,830

 

 

$ 0.41

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

5,909,716

 

 

$ 0.22

 

 

 

 

 

 

Options exercised

 

 

(2,096,970 )

 

$ 0.05

 

 

 

 

 

 

Options forfeited

 

 

(4,584,010 )

 

$ 0.19

 

 

 

 

 

 

Options expired

 

 

-

 

 

$ -

 

 

 

 

 

 

Options outstanding as of June 30, 2021

 

 

16,721,566

 

 

$ 0.45

 

 

8.7 years

 

$ 2,943

 

Options exercisable as of June 30, 2021

 

 

8,225,610

 

 

$ 0.72

 

 

9.0 years

 

$ 1,119

 

Schedule of Stock based compensation assumptions

 

 

For the Three Months Ended

 

 

 

June 30, 2021

 

 

June 30, 2020

 

Type of Award

 

Number of Shares or Options Granted

 

 

Stock-Based Compensation Expense

 

 

Number of Shares or Options Granted

 

 

Stock-Based Compensation Expense

 

 

 

 

 

 

 

 

Stock options

 

 

5,409,716

 

 

$ 641

 

 

 

9,650,000

 

 

$ 294

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock grants:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Directors (common stock)

 

 

343,493

 

 

 

94

 

 

 

(173,610 )

 

$ (100 )(a)

Employees (common stock)

 

 

250,000

 

 

 

68

 

 

 

826,429

 

 

$ 58

 

Non–employee consultants (common stock)

 

 

-

 

 

 

-

 

 

 

250,000

 

 

$ 32

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock–based compensation expense

 

 

 

 

 

$ 803

 

 

 

 

 

 

$ 284

 

 

 

For the Six Months Ended

 

 

 

June 30, 2021

 

 

June 30, 2020

 

Type of Award

 

Number of Shares or Options Granted

 

 

Stock-Based Compensation Expense

 

 

Number of Shares or Options Granted

 

 

Stock-Based Compensation Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

5,909,716

 

 

$ 885

 

 

 

9,650,000

 

 

$ 1,238

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock grants:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Directors (common stock)

 

 

885,159

 

 

 

214

 

 

 

(173,610 )

 

 

(100 )(a)

Employees (common stock)

 

 

250,000

 

 

 

67

 

 

 

3,179,544

 

 

 

58 (b)

Non–employee consultants (common stock)

 

 

332,947

 

 

 

32

 

 

 

1,075,000

 

 

 

48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock–based compensation expense

 

 

 

 

 

$ 1,198

 

 

 

 

 

 

$ 1,244